Cargando…

Substantial impact of 3-iodothyronamine (T1AM) on the regulations of fluorescent thermoprobe-measured cellular temperature and natriuretic peptide expression in cardiomyocytes

There is growing interest in 3-iodothyronamine (T1AM), an active thyroid hormone metabolite, that induces negative inotropic and chronotropic actions in the heart and exerts systemic hypothermic action. We explored the direct impact of T1AM on cardiomyocytes with a focus on the regulation of the int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Hirotake, Nagoshi, Tomohisa, Kimura, Haruka, Tanaka, Yoshiro, Yasutake, Rei, Oi, Yuhei, Yoshii, Akira, Tanaka, Toshikazu D., Kashiwagi, Yusuke, Yoshimura, Michihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325765/ https://www.ncbi.nlm.nih.gov/pubmed/35882940 http://dx.doi.org/10.1038/s41598-022-17086-2

Ejemplares similares

The thermogenic actions of natriuretic peptide in brown adipocytes: The direct measurement of the intracellular temperature using a fluorescent thermoprobe
por: Kimura, Haruka, et al.
Publicado: (2017)

Treatment with atrial natriuretic peptide induces adipose tissue browning and exerts thermogenic actions in vivo
por: Kimura, Haruka, et al.
Publicado: (2021)

Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity
por: Oi, Yuhei, et al.
Publicado: (2022)

URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease
por: Tanaka, Yoshiro, et al.
Publicado: (2023)

Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure
por: Takahashi, Hirotake, et al.
Publicado: (2021)

Close linkage between blood total ketone body levels and B-type natriuretic peptide levels in patients with cardiovascular disorders
por: Kashiwagi, Yusuke, et al.
Publicado: (2021)

URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice
por: Tanaka, Yoshiro, et al.
Publicado: (2021)

Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
por: Yoshii, Akira, et al.
Publicado: (2019)

Effects of angiotensin receptor‐neprilysin inhibitor on insulin resistance in patients with heart failure
por: Kashiwagi, Yusuke, et al.
Publicado: (2023)

Collaborative Activities of Noradrenaline and Natriuretic Peptide for Glucose Utilization in Patients with Acute Coronary Syndrome
por: Uno, Goki, et al.
Publicado: (2019)

Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis
por: Tanaka, Yoshiro, et al.
Publicado: (2017)

Coronary artery disease concomitant with immunoglobulin G4-related disease: a case report and literature review
por: Okuyama, Toraaki, et al.
Publicado: (2019)

Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study
por: Tominaga, Mitsutoshi, et al.
Publicado: (2019)

Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis
por: Ito, Satoshi, et al.
Publicado: (2017)

Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor
por: Tsutsumi, Joshi, et al.
Publicado: (2017)

High Serum Uric Acid is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases
por: Oki, Yoshitsugu, et al.
Publicado: (2019)

Therapeutic hypothermia after cardiac arrest increases the plasma level of B-type natriuretic peptide
por: Kashiwagi, Yusuke, et al.
Publicado: (2020)

Conflicting relationship between age-dependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide
por: Fukumoto, Risa, et al.
Publicado: (2017)

Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)
por: Gencarelli, Manuela, et al.
Publicado: (2022)

Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice
por: Kashiwagi, Yusuke, et al.
Publicado: (2015)

Parallel comparison of risk factors between progression of organic stenosis in the coronary arteries and onset of acute coronary syndrome by covariance structure analysis
por: Ogawa, Kazuo, et al.
Publicado: (2017)

Heart Failure Treatments Such As Angiotensin Receptor/Neprilysin Inhibitor Improve Heart Failure Status and Glucose Metabolism
por: Kashiwagi, Yusuke, et al.
Publicado: (2022)

Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
por: Ogawa, Kazuo, et al.
Publicado: (2015)

Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2023)

A Highly-sensitized Response of B-type Natriuretic Peptide to Cardiac Ischaemia Quantified by Intracoronary Pressure Measurements
por: Itakura, Ryosuke, et al.
Publicado: (2020)

The Plasma B-Type Natriuretic Peptide Levels Are Low in Males with Stable Ischemic Heart Disease (IHD) Compared to Those Observed in Patients with Non-IHD: A Retrospective Study
por: Minai, Kosuke, et al.
Publicado: (2014)

Modulation of cardiac ionic homeostasis by 3-iodothyronamine
por: Ghelardoni, Sandra, et al.
Publicado: (2009)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway
por: Rogowski, Michael, et al.
Publicado: (2019)

Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)
por: Haiyan, Zhou, et al.
Publicado: (2020)

A Pilot Evaluation Study of Diffuse Coronary Arterial Contraction Causing Ischemia by Double Measurement of Left Ventriculography Before and After Intracoronary Administration of Nitrates
por: Minai, Kosuke, et al.
Publicado: (2021)

Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report
por: Tanaka, Toshikazu D., et al.
Publicado: (2021)

Update on 3-iodothyronamine and its neurological and metabolic actions
por: Zucchi, Riccardo, et al.
Publicado: (2014)

Constrictive Pericarditis with Cardiac Ascites Caused Spontaneous Bacterial Peritonitis
por: Kashiwagi, Yusuke, et al.
Publicado: (2021)

Unique crosstalk between platelet and leukocyte counts during treatment for acute coronary syndrome: A retrospective observational study
por: Shirasaki, Keisuke, et al.
Publicado: (2022)

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression
por: Assadi-Porter, Fariba M., et al.
Publicado: (2018)

Effect of Combined Levothyroxine (L-T(4)) and 3-Iodothyronamine (T(1)AM) Supplementation on Memory and Adult Hippocampal Neurogenesis in a Mouse Model of Hypothyroidism
por: Rutigliano, Grazia, et al.
Publicado: (2023)

3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes
por: Gencarelli, Manuela, et al.
Publicado: (2020)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kh2gjqd2j44h455cucfl0keo46